Press Releases :: CV Sciences, Inc. (CVSI)

Investors

Investors

CV Sciences is a consumer wellness company specializing in nutraceuticals and plant-based foods.

Press Releases

CV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco Addiction

Mar 23, 2023

CV Sciences, Inc. Launches New Line of THC-Free Gummies and Softgels

Mar 21, 2023

CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation

Mar 2, 2023

CV Sciences, Inc. Launches 30-Count of Popular +PlusCBD™ Reserve Collection Softgels

Jan 19, 2023

CV Sciences, Inc. Launches 30-Count of Popular +PlusCBD™ Reserve Collection Softgels

Jan 18, 2023

CV Sciences, Inc. Reports Third Quarter 2022 Financial Results

Nov 14, 2022

CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2022 RESULTS ON NOVEMBER 14, 2022

Nov 8, 2022

CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation

Sep 27, 2022

CV Sciences, Inc. Extinguishes Convertible Debt

Aug 25, 2022

CV Sciences, Inc. Announces Launch of PlusCBD™ Reserve Collection Softgels

Aug 15, 2022